Trial Profile
Phase I single-dose trial of seridopidine in volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Oct 2012
Price :
$35
*
At a glance
- Drugs Seridopidine (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Pharmacokinetics
- 25 Oct 2012 Status changed from recruiting to completed, as reported in a NeuroSearch A/S media release.
- 20 Dec 2007 New trial record.
- 18 Dec 2007 NeuroSearch reports that dosing has begun.